Reported value$185K12,000 shares at $15.40
For this personUnusual1 buy · 0 sales on file
Similar buys beat S&P43%166 cases · all buys 46%
Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- 4 different insiders bought in the last 90 days.
Reasons for caution
- Similar past buys beat the S&P 500 only 43% of the time (166 cases); the typical one trailed it by 3.4%.
What happened after this filing
7 days
Pending
due Nov 3
30 days
Pending
due Nov 26
90 days
Pending
due Jan 25
Insider Twins: past buys with the same traits
3+ insiders buying · incl. CEO or CFO · $1M+ · stock down 0–20% in 3 months
CTEV May 20, 2025 +142.5% vs S&PABCL May 17, 2022 +60.7% vs S&PAMRX Mar 11, 2020 +50.4% vs S&PRPD Dec 4, 2025 -58.9% vs S&PMODD Dec 4, 2024 -50.8% vs S&PSBSW Apr 1, 2026 -45.9% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
Summary
Carrie L Boer (a director) bought $185K of NPB at about $15.40 on Oct 23, 2026, reported to the SEC on Oct 27, 2026. Buys like this beat the S&P 500 43% of the time since 2020, against 46% for all insider buys. We found 2 points that make it worth a closer look and 1 reason for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the NPB alerts below.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.